Low-dose dexmedetomidine as an adjuvant to propofol infusion for children in MRI: A double-cohort study.
Makoto Nagoshi, Swayta Reddy, Marisa Bell...
https://pubmed.ncbi.nlm.nih.gov/29882298Actively Recruiting
Led by Boston Children's Hospital · Updated on 2026-05-29
105
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are evaluating sedation methods for children aged 1 to 12 years undergoing magnetic resonance imaging (MRI). The study focuses on comparing the use of propofol alone versus a combination of dexmedetomidine and propofol to find the best sedation approach that minimizes anesthetic exposure while maintaining effective sedation. This research is motivated by concerns about possible neurotoxic effects of common anesthetics and the potential benefits of dexmedetomidine, which may reduce risks like airway collapse and pulmonary issues. Participants will be randomly assigned to one of three sedation plans: propofol only, high-dose dexmedetomidine with propofol, or low-dose dexmedetomidine with propofol. Each plan involves specific dosing schedules, including intravenous boluses and continuous propofol infusions, adjusted to maintain a targeted sedation level. Lidocaine is also given as part of the standard care protocol. The study aims to find the optimal dose of dexmedetomidine combined with propofol that provides adequate sedation without prolonging recovery time. During the MRI procedure, sedation depth will be closely monitored using sedation scores, and researchers will track propofol consumption, recovery duration, and any adverse events or interruptions. Various assessments will be conducted during and after the MRI, including measuring emergence delirium and sedation scores, as well as observing patient movements and technique failures. The total observation time includes the MRI scan and post-anesthesia care unit (PACU) stay, ensuring comprehensive safety and effectiveness monitoring throughout the sedation and recovery periods.
CONDITIONS
Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 90 minutes or duration of MRI scan
Participants receive sedation with either propofol only or a combination of dexmedetomidine and propofol during their MRI procedure. Sedation includes IV boluses and infusions to achieve and maintain a specific sedation level.
1 visit (in-person) on the day of MRI
Duration - Up to 180 minutes or duration of PACU stay
Participants are monitored in the Post Anesthesia Care Unit (PACU) following sedation until recovery is adequate.
Approximately 1 follow-up visit (in-person) immediately after MRI
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
S
Samuel Kim, BS
R
Rachel Bernier, MPH
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Makoto Nagoshi, Swayta Reddy, Marisa Bell...
https://pubmed.ncbi.nlm.nih.gov/29882298Shwethashri Kondavagilu Ramaprasannakumar, Varadarajan Bhadrinarayan, Sudhir Venkataramaiah
https://pubmed.ncbi.nlm.nih.gov/36620110Juan P Boriosi, Jens C Eickhoff, Kristi B Klein...
https://pubmed.ncbi.nlm.nih.gov/27779360Amy E Vinson, James Peyton, Anna Kordun...
https://pubmed.ncbi.nlm.nih.gov/34036674Samuel Y Kim, Jocelyn M Booth, Steven J Staffa...
https://pubmed.ncbi.nlm.nih.gov/40349256Bob A Rappaport, Santhanam Suresh, Sharon Hertz...
https://pubmed.ncbi.nlm.nih.gov/25714157Michael D Mallory, Curtis Travers, Joseph P Cravero...
https://pubmed.ncbi.nlm.nih.gov/36173243